Restora Neurosciences

Restora Neurosciences is a pre-clinical stage biotechnology company focused on developing novel therapeutics for neuropsychiatric and neurological disorders. The company's primary focus is on modulating the glutamatergic system, specifically targeting NMDA receptors to address conditions such as treatment-resistant depression and post-traumatic stress disorder. By leveraging insights into neuroplasticity and synaptic function, Restora aims to create rapid-acting and long-lasting treatments that overcome the limitations of current standard-of-care antidepressants. Their research also extends to potential applications in traumatic brain injury and other cognitive impairments.